Blue Horizon Enterprise Ltd, 10% Owner at Stoke Therapeutics, Inc. (STOK), sold 1,937,500 shares at $14.05 ($27.2M) on 2024-09-19, disclosed to the SEC on 2024-09-23.
Open-market sale of $27.2M STOK by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |